Predictive factors of [18F]-Choline PET/CT in 170 patients with increasing PSA after primary radical treatment-Reference-Cited by-同舟云学术

Predictive factors of [18F]-Choline PET/CT in 170 patients with increasing PSA after primary radical treatment

Published:2012-11-27 Issue:3 Volume:139 Page:521-528
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Detti Beatrice,Scoccianti Silvia,Franceschini Davide,Cipressi Samantha,Cassani Sara,Villari Donata,Gacci Mauro,Pupi Alberto,Vaggelli Luca,Saieva Calogero,Pertici Maurizio,Livi Lorenzo,Ceroti M.,Nicita Giulio,Carini Marco,Biti Giampaolo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-012-1354-4.pdf

Reference32 articles.

1. Breeuwsma AJ, Pruim J, van den Bergh AC et al (2010) Detection of local, regional, and distant recurrence in patients with PSA relapse after external-beam radiotherapy using (11)C-Choline positron emission tomography. Int J Radiat Oncol Biol Phys 77:160–164

2. Castellucci P, Fuccio C, Nanni C, Santi I, Rizzello A, Lodi F et al (2009) Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med 50:1394–1400

3. Castellucci P, Fuccio C, Rubello D et al (2011) Is there a role for 11C-Choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? Eur J Nucl Med Mol Imaging 38:55–63

4. Cimitan M, Bortolus R, Morassut S et al (2006) [(18)F] fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 33:1387–1398

5. Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S et al (2011) Use of [11C]Choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression. Clin Cancer Res 17:7673–7683

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Advances: Innovative Techniques and Biomarkers for Prostate Cancer Diagnosis;Transforming Prostate Cancer Care;2024

2. Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives;Cancers;2023-09-27

3. Choline PET/CT in recurrent prostate cancer;Frontiers in Oncology;2023-03-21

4. The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis;Frontiers in Oncology;2021-06-17

5. Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy;J NUCL MED;2020